Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic–ischemic brain injury in rats

The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic–ischemic injury in fetal lambs

(2010) Daniel Alonso-Alconada et al.   BRAIN RESEARCH

CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices

(2010) Elisa Landucci et al.   NEUROPHARMACOLOGY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia

(2008) Markus Schomacher et al.   BRAIN RESEARCH

Mechanisms of Control of Neuron Survival by the Endocannabinoid System

(2008) Ismael Galve-Roperh et al.   CURRENT PHARMACEUTICAL DESIGN

Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death

(2008) Domenico E. Pellegrini-Giampietro et al.   FEBS Journal

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation

(2008) Jian Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury

(2008) M. Zhang et al.   NEUROSCIENCE

The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation

(2007) F Comelli et al.   BRITISH JOURNAL OF PHARMACOLOGY

Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats

(2007) Silvia Carloni et al.   JOURNAL OF PINEAL RESEARCH